A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion

Table 2

		Mean (±SD) [IU/mL]		Area under curve [AUC] (95% CI)
CA19-9	PDAC	636,05 (±2443,77)	<0,0001	0,736 (0,676–0,795)
	benign	62,36 (±134,7)
Ca125	PDAC	45,37 (±89,05)	<0,0001	0,717 (0,653–0,782)
	benign	12,74 (±16,65)
Ca15-3	PDAC	46,03 (±301,33)	0,027	0,582 (0,515–0,649)
	benign	15,77 (±7,91)
CEA	PDAC	11,95 (±44,5)	0,043	0,598 (0,527–0,670)
	benign	5,44 (±25,69)